The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota
Kaitlyn D. LaCourse(Fred Hutch Cancer Center), Susan Bullman(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Christopher D. Johnston(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Alexander Baryiames(Fred Hutch Cancer Center), Samuel S. Minot(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Andrew G. Kempchinsky(Fred Hutch Cancer Center), Martha A. Zepeda‐Rivera(Fred Hutch Cancer Center)
Cited by 162
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
The human gut virome: Inter-individual variation and dynamic response to diet
|Genome Research|2011|963
<i>Fusobacterium nucleatum</i>and T Cells in Colorectal Carcinoma
|JAMA Oncology|2015|660
Rapid evolution of the human gut virome
|Proceedings of the National Academy of Sciences|2013|632